There are no products listed under this category.
SCN4B
SCN4B (sodium voltage-gated channel beta subunit 4, also known as LQT10) is a transmembrane regulatory subunit of voltage-gated sodium (Nav) channels. It helps localise and functionally modulate the pore-forming alpha subunits that depolarise excitable membranes. Browse Assay Genie's current range of SCN4B research reagents below, or read on for the biology behind the target.
SCN4B is a regulatory subunit of multiple voltage-gated sodium channels, which are also called VGSCs or VDSCs. Nav channels switch between closed and open conformations depending on the voltage difference across the membrane. In the open state they let Na+ ions pass selectively through the pore, down their electrochemical gradient. The resulting influx depolarises the membrane and starts the propagation of electrical signals through cells and tissues. As an accessory beta subunit, SCN4B takes part in the localisation and functional modulation of these channels. It modulates the activity of SCN1A (Nav1.1) and SCN2A (Nav1.2).
The SCN4B gene encodes one of several sodium channel beta subunits. These subunits interact with voltage-gated alpha subunits to change sodium channel kinetics. The encoded protein is a transmembrane protein that sits in the cell membrane, and it forms interchain disulfide bonds with SCN2A. HGNC classes it among the V-set domain containing proteins and the sodium voltage-gated channel beta subunits, and UniProt places it in the sodium channel auxiliary subunit SCN4B family. Three protein-coding transcript variants and one non-coding variant have been reported for the gene. Mouse and rat both have an Scn4b ortholog.
Defects in the SCN4B gene are a cause of long QT syndrome type 10, which explains the alias LQT10. Earlier names for the gene include sodium channel, voltage-gated, type IV, beta subunit. Researchers studying the SCN4B protein often do so alongside other sodium channel subunits, to understand how auxiliary subunits shape channel behaviour in excitable tissues.
SCN4B interacts with alpha subunits to change sodium channel kinetics, making it relevant to studies of channel gating and modulation.
Defects in SCN4B cause long QT syndrome type 10, linking the gene to inherited disorders of cardiac repolarisation.
Nav channels drive membrane depolarisation and the propagation of electrical signals, and SCN4B contributes to their localisation and function.
SCN4B forms interchain disulfide bonds with SCN2A and modulates SCN1A and SCN2A, supporting work on alpha-beta subunit assembly.
SCN4B is a regulatory beta subunit of voltage-gated sodium channels. It participates in channel localisation and functional modulation, and it alters sodium channel kinetics through interaction with alpha subunits. It modulates SCN1A (Nav1.1) and SCN2A (Nav1.2), which mediate depolarisation of excitable membranes.
SCN4B is also known as LQT10, after its link to long QT syndrome type 10. UniProt lists it as sodium channel regulatory subunit beta-4. Older names include sodium channel, voltage-gated, type IV, beta subunit. Three protein-coding transcript variants have been described.
Mouse and rat each have an Scn4b ortholog. In humans, defects in the SCN4B gene are a cause of long QT syndrome type 10. Check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.
Other sodium channel subunits, including beta subunits, voltage-gated alpha subunits and epithelial sodium channel components.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IWT1; product specifications from Assay Genie datasheets.
There are no products listed under this category.